Stock listing
TPEx:4167 Savior Lifetec Corp. (松瑞藥) 股價
Follow Savior Lifetec Corp. into a list and get an email when it puts out news.
Share price · TPEX:4167
$15.75 TWD -1.80 (-10.3%)
Close on Nov 20, 2026
- Day range
- $15.75 – $16.85 TWDNov 20, 2026
- Volume
- 2.03M sharesNov 20, 2026
- Market cap
- $5.22B TWDAt the close on Nov 20, 2026 · price × 331.6M shares outstanding
- 52-week range
- $15.75 – $23.95 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $32.54M TWDMedian day 978,182 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4167 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.75 | -1.80 | -10.3% | $16.85 | $16.85 | $15.75 | 2,034,721 | |
| $17.55 | -0.45 | -2.5% | $18.25 | $18.25 | $17.45 | 1,548,168 | |
| $18.00 | -0.10 | -0.6% | $17.90 | $18.10 | $17.75 | 1,431,882 | |
| $18.10 | -1.05 | -5.5% | $19.20 | $19.20 | $18.10 | 1,425,007 | |
| $19.15 | +0.15 | +0.8% | $19.20 | $19.45 | $19.05 | 983,583 | |
| $19.00 | -0.25 | -1.3% | $19.30 | $19.35 | $18.90 | 943,045 | |
| $19.25 | +0.25 | +1.3% | $19.10 | $19.35 | $18.75 | 1,173,949 | |
| $19.00 | +0.05 | +0.3% | $19.05 | $19.35 | $18.80 | 1,027,237 | |
| $18.95 | +0.55 | +3.0% | $18.90 | $19.35 | $18.60 | 1,241,102 | |
| $18.40 | -0.50 | -2.6% | $17.55 | $18.65 | $17.55 | 2,100,188 | |
| $18.90 | -0.65 | -3.3% | $19.50 | $19.80 | $18.75 | 1,769,596 | |
| $19.55 | +0.05 | +0.3% | $19.50 | $19.65 | $19.10 | 1,001,910 | |
| $19.50 | -0.45 | -2.3% | $19.85 | $20.05 | $19.45 | 1,429,062 | |
| $19.95 | -0.15 | -0.7% | $19.95 | $20.10 | $19.90 | 790,583 | |
| $20.10 | -0.30 | -1.5% | $20.30 | $20.30 | $20.00 | 1,300,460 | |
| $20.40 | -0.10 | -0.5% | $20.50 | $20.55 | $20.20 | 898,573 | |
| $20.50 | -0.10 | -0.5% | $20.60 | $20.70 | $20.30 | 1,045,889 | |
| $20.60 | -0.30 | -1.4% | $20.90 | $21.25 | $20.55 | 1,776,089 | |
| $20.90 | 0.00 | 0.0% | $20.90 | $20.90 | $20.90 | 0 | |
| $20.90 | 0.00 | 0.0% | $20.80 | $20.95 | $20.75 | 1,046,905 | |
| $20.90 | +0.15 | +0.7% | $20.75 | $21.05 | $20.65 | 1,216,627 | |
| $20.75 | +0.10 | +0.5% | $20.65 | $20.80 | $20.50 | 1,385,531 | |
| $20.65 | -1.15 | -5.3% | $21.80 | $21.80 | $20.45 | 3,279,242 | |
| $21.80 | +0.05 | +0.2% | $21.75 | $22.10 | $21.65 | 1,285,266 | |
| $21.75 | -0.40 | -1.8% | $21.85 | $22.45 | $21.60 | 2,779,456 | |
| $22.15 | -0.25 | -1.1% | $22.50 | $22.50 | $22.00 | 4,101,642 | |
| $22.40 | +0.75 | +3.5% | $21.25 | $22.45 | $21.20 | 6,548,744 | |
| $21.65 | -0.35 | -1.6% | $23.30 | $23.95 | $21.40 | 13,148,541 | |
| $22.00 | +1.55 | +7.6% | $20.95 | $22.40 | $20.95 | 9,651,254 | |
| $20.45 | +1.00 | +5.1% | $19.45 | $20.85 | $19.45 | 4,548,594 | |
| $19.45 | 0.00 | 0.0% | $19.45 | $19.65 | $19.40 | 563,232 | |
| $19.45 | -0.10 | -0.5% | $19.60 | $19.65 | $19.35 | 453,773 | |
| $19.55 | -0.05 | -0.3% | $19.60 | $19.60 | $19.40 | 576,391 | |
| $19.60 | -0.25 | -1.3% | $19.80 | $19.95 | $19.55 | 470,993 | |
| $19.85 | +0.30 | +1.5% | $19.65 | $19.90 | $19.45 | 848,882 | |
| $19.55 | +0.15 | +0.8% | $19.50 | $19.60 | $19.40 | 536,088 | |
| $19.40 | -0.30 | -1.5% | $19.70 | $19.70 | $19.30 | 597,411 | |
| $19.70 | -0.05 | -0.3% | $19.80 | $19.90 | $19.70 | 630,159 | |
| $19.75 | +0.10 | +0.5% | $19.50 | $19.80 | $19.50 | 699,811 | |
| $19.65 | 0.00 | 0.0% | $19.35 | $19.70 | $19.35 | 517,741 | |
| $19.65 | +0.15 | +0.8% | $19.45 | $19.65 | $19.20 | 994,557 | |
| $19.50 | +0.40 | +2.1% | $19.10 | $19.55 | $19.00 | 1,148,166 | |
| $19.10 | +0.05 | +0.3% | $19.20 | $19.20 | $19.05 | 420,343 | |
| $19.05 | +0.20 | +1.1% | $18.90 | $19.20 | $18.90 | 362,488 | |
| $18.85 | -0.10 | -0.5% | $18.85 | $19.00 | $18.70 | 457,032 | |
| $18.95 | -0.15 | -0.8% | $19.00 | $19.05 | $18.90 | 477,049 | |
| $19.10 | 0.00 | 0.0% | $19.05 | $19.15 | $19.00 | 533,932 | |
| $19.10 | +0.20 | +1.1% | $19.05 | $19.20 | $18.95 | 865,863 | |
| $18.90 | 0.00 | 0.0% | $18.95 | $19.15 | $18.80 | 504,550 | |
| $18.90 | -0.25 | -1.3% | $19.20 | $19.20 | $18.80 | 544,604 | |
| $19.15 | +0.15 | +0.8% | $19.05 | $19.25 | $18.80 | 854,216 | |
| $19.00 | -0.35 | -1.8% | $19.50 | $19.50 | $19.00 | 912,438 | |
| $19.35 | -0.15 | -0.8% | $19.50 | $19.55 | $19.30 | 451,384 | |
| $19.50 | -0.25 | -1.3% | $19.65 | $19.85 | $19.40 | 902,653 | |
| $19.75 | -0.25 | -1.3% | $20.10 | $20.10 | $19.60 | 972,780 | |
| $20.00 | -0.15 | -0.7% | $20.55 | $20.55 | $19.95 | 619,357 | |
| $20.15 | -0.10 | -0.5% | $20.25 | $20.25 | $20.10 | 581,040 | |
| $20.25 | 0.00 | 0.0% | $20.30 | $20.50 | $20.15 | 586,320 | |
| $20.25 | -0.15 | -0.7% | $20.45 | $20.65 | $20.25 | 840,449 | |
| $20.40 | -0.55 | -2.6% | $20.85 | $21.10 | $20.35 | 1,191,258 | |
| $20.95 | +0.25 | +1.2% | $20.70 | $21.20 | $20.50 | 2,234,950 | |
| $20.70 | +0.85 | +4.3% | $19.95 | $21.00 | $19.95 | 3,210,372 |
Splits
2 splits since 2021 · TPEX:4167 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1.068-for-1 | Split | |
| 99-for-94 | Split |
- Ticker
- TPEx:4167
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- TPEx
- Currency
- TWD
Latest news
Savior Lifetec Corp. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 16 in all · newest Aug 5, 2022 · oldest 2022
- Decks
- 4 decks · latest Nov 22, 2023
Valuation
P/E 5.1× against a median of 30.6×: the lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.50B TWD
- P/E
- 5.1×
- EV/sales
- 2.2×
- EV/EBITDA
- 12.1×
- Price/book
- 1.2×
- Gross margin
- 33.4%
- Operating margin
- 11.1%
- Net margin
- 91.9%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Savior Lifetec Corp. · TPEX:4167 | US$158.4M | US$75.85M | 5.1× | 2.2× | 12.1× | 1.2× | 91.9% | 0.0× | n/a |
| CF PharmTech. Inc. Class H · HKEX:2652 | US$173.6M | US$114.7M | 466× | 1.8× | 12.4× | 0.9× | 0.6% | 0.1× | n/a |
| SIGA Technologies Inc. · NASDAQ:SIGA | US$172.5M | US$56.35M | 251× | 1.1× | n/a | 1.1× | 1.3% | 0.0× | 1.01 |
| Searle Company Ltd · PSX:SEARL | US$169.6M | US$163.7M | 68.6× | 1.2× | 6.4× | 1.4× | 1.8% | 0.0× | n/a |
| Dawnrays Pharmaceutical Holdings Ltd. · HKEX:2348 | US$165.1M | −US$72.72M | 5.2× | −0.4× | −1.4× | 0.3× | 17.4% | 0.0× | n/a |
| SCI Pharmtech Corp. · TWSE:4119 | US$164.3M | US$193.9M | 90.0× | 5.1× | 17.8× | 1.0× | 4.8% | 0.2× | n/a |
| Binh Dinh Pharmaceutical & Medical Equipment JSC · HOSE:DBD | US$161.0M | US$149.0M | 13.2× | 2.0× | 10.5× | 2.3× | 16.6% | 0.1× | n/a |
| AGP Limited · PSX:AGP | US$153.6M | US$167.2M | 12.0× | 1.7× | 6.0× | 2.8× | 13.4% | 0.3× | n/a |
| Whan In Pharmaceutical Co., Ltd. · KRX:016580 | US$151.2M | US$101.3M | 9.9× | 0.5× | 4.2× | 0.5× | 7.5% | 0.0× | n/a |
| Jagsonpal Pharmaceuticals Ltd. · NSE:JAGSNPHARM | US$149.2M | US$127.4M | 30.6× | 3.7× | 19.2× | 5.8× | 14.3% | 0.0× | n/a |
| Vivozon Pharmaceutical Co., Ltd. · KRX:082800 | US$147.5M | US$139.5M | n/a | 3.7× | n/a | 2.1× | −65.2% | 0.0× | n/a |
| Median of the others | US$162.6M | US$133.4M | 30.6× | 1.8× | 8.4× | 1.2× | 6.1% | 0.0× | 1.01 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 2, 2023 · After close | +1.4% |
| Q3 2022 | Nov 10, 2022 · Before open | +0.6% |
| Q1 2022 | May 5, 2022 · After close | −2.8% |
| Q4 2021 | Mar 20, 2022 · After close | +3.4% |
| Q3 2021 | Nov 3, 2021 · After close | +2.2% |
| Quarter to Jun 30, 2021 | Aug 5, 2021 · After close | −0.6% |
| Quarter to Mar 31, 2021 | May 13, 2021 · After close | +3.1% |
| Quarter to Dec 31, 2020 | Mar 18, 2021 · After close | +3.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 9M23 Earnings Presentation | Earnings | 22 slides | Nov 22, 2023 |
| Q3 2023 Earnings Presentation | Earnings | 22 slides | Nov 22, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 24 slides | Nov 10, 2022 |
| Q3 2022 Earnings Presentation | Earnings | 24 slides | Nov 10, 2022 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.20B | 1.22B | 1.05B | 1.27B | 1.74B | 1.83B | 1.32B | 1.10B | 1.62B | 1.53B |
| Cost of revenue | 778.3M | 870.6M | 829.3M | 1.13B | 1.44B | 1.27B | 967.7M | 1.18B | 1.18B | 1.35B |
| Gross profit | 423.4M | 346.8M | 220.9M | 131.0M | 307.9M | 558.6M | 351.0M | -70.5M | 440.3M | 186.9M |
| Research and development | 67.2M | 75.1M | 111.0M | 119.1M | 167.3M | 179.1M | 187.7M | 142.8M | 215.8M | 242.7M |
| Selling, general and administrative | 158.0M | 152.7M | 76.1M | 76.3M | 79.7M | 97.5M | 72.8M | 73.5M | 68.3M | 65.5M |
| Operating income | 198.2M | 118.9M | -2.42M | 52.0M | 24.7M | 287.0M | 34.2M | -357.8M | 106.0M | -183.1M |
| Depreciation and amortization | 92.1M | 127.0M | 182.2M | 208.7M | 238.7M | 221.6M | 213.3M | 206.5M | 202.8M | 207.3M |
| EBITDA | 290.3M | 245.9M | 179.7M | 260.7M | 263.3M | 508.7M | 247.5M | -151.3M | 308.8M | 24.3M |
| Interest expense | 5.43M | 7.48M | 9.87M | 15.7M | 17.9M | 24.2M | 31.9M | 17.5M | 26.9M | 35.9M |
| Income before tax | 534.1M | 179.4M | 27.5M | 36.3M | 9.96M | 250.9M | -4.93M | -359.5M | 22.3M | -207.7M |
| Income tax | 42.0K | 15.7M | 14.7M | 36.1M | 39.1M | 15.8M | -56.8M | 11.3M | ||
| Net income | 537.4M | 182.4M | 30.0M | 20.6M | -4.76M | 250.9M | -44.0M | -359.5M | 22.3M | -207.7M |
| Earnings per share, basic | 1.62 | 0.54 | 0.09 | 0.07 | -0.01 | 0.75 | -0.16 | -1.38 | 0.09 | -0.84 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 823.4M | 1.36B | 1.08B | 1.09B | 491.4M | 682.6M | 559.0M | 384.0M | 674.0M | 476.6M |
| Short-term investments | 789.0M | 761.1M | 254.3M | 563.8M | 15.7M | 119.6M | 24.1M | 77.4M | 420.0K | |
| Receivables | 286.0M | 239.8M | 342.6M | 410.0M | 1.09B | 671.5M | 294.2M | 190.1M | 309.5M | 337.7M |
| Inventory | 573.4M | 670.8M | 860.0M | 1.04B | 1.31B | 1.08B | 849.7M | 1.01B | 788.3M | 681.9M |
| Current assets | 2.56B | 3.25B | 2.55B | 3.10B | 2.91B | 2.55B | 1.73B | 1.67B | 2.06B | 1.53B |
| Property, plant and equipment | 1.27B | 1.59B | 2.25B | 2.28B | 1.85B | 1.86B | 1.89B | |||
| Total assets | 4.18B | 4.38B | 3.82B | 4.41B | 4.54B | 4.84B | 4.03B | 3.53B | 3.95B | 3.44B |
| Accounts payable | 45.3M | 42.2M | 54.2M | 69.8M | 43.2M | 115.6M | 27.2M | 122.9M | 169.8M | 133.8M |
| Current liabilities | 231.2M | 690.4M | 200.9M | 778.5M | 298.3M | 570.8M | 1.31B | 875.4M | 929.7M | 738.8M |
| Long-term debt | 0 | 523.7M | 520.9M | 93.3M | 798.1M | 854.9M | 578.7M | |||
| Total debt | 270.4M | 803.3M | 951.3M | 959.0M | 1.45B | 1.10B | 944.9M | 670.5M | ||
| Total liabilities | 403.3M | 860.0M | 458.0M | 1.04B | 1.23B | 1.51B | 1.82B | 1.67B | 1.78B | 1.32B |
| Shareholders' equity | 3.78B | 3.51B | 3.35B | 3.35B | 3.31B | 3.33B | 2.21B | 1.86B | 2.16B | 2.12B |
| Shares outstanding | 331.6M | 339.0M | 338.6M | 317.1M | 317.5M | 336.7M | 271.3M | 260.3M | 260.1M | 247.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -21.0M | 518.4M | 388.0M | 581.8M | -168.3M | 91.3M | 156.4M | -189.8M | 260.9M | -76.1M |
| Capital spending | -143.2M | -118.5M | -17.9M | -34.2M | -95.6M | -216.5M | -199.3M | -204.7M | -131.9M | -78.0M |
| Free cash flow | -164.3M | 399.9M | 370.1M | 547.6M | -263.9M | -125.3M | -42.9M | -394.5M | 129.0M | -154.1M |
| Cash from investing | 20.3M | 18.5M | -311.8M | -145.8M | -2.43M | -384.9M | -72.2M | |||
| Cash from financing | -572.2M | -7.48M | -41.4M | 344.1M | 164.4M | -97.8M | 321.5M | 346.7M | ||
| Dividends paid | -127.0M | -27.0M | -32.7M | -40.0M | -40.0M | -40.0M | -40.0M | |||
| Share buybacks | -138.6M | 0 | 19.1M | -495.0K | -985.0K | -490.0K | -1.17M | |||
| Change in cash | -534.7M | 275.1M | -3.07M | 594.6M | -191.2M | 123.6M | 175.0M | -290.0M | 197.4M | 198.5M |
Cap table
Built by 6ix from Savior Lifetec Corp.’s releases
- Common shares
- 331,554,306
- Fully diluted
- 331,554,306
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 331,554,306 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 331,554,306 |
Log in to ask 6ix AI your own questions about Savior Lifetec Corp.